Malaria Treatment - Regal Flashcards
Suppressive Prophylactic Treatment
Malaria: Chloroquine
2nd: Atovaquone/proguanil
Chloroquine-Resistant Malaria: Atovaquone/proguanil
2nd: Doxycycline or Mefloquine
Clinical status of Severe Malaria Disease
Most deaths from severe malaria occur within the first 24-48 hours, so we need a parenteral therapy that acts quickly
Why is Primaquine considered the “radical cure”?
It acts on the latent hepatozoite Exoerythrocytic forms of P. vivax and P. ovale
What type of plasmodium have the most resistance to treatment?
P. vivax
P. falciparum
What type of plasmodium have a persistent hepatic form?
P. vivax
P. ovale
Atovaquone/Proguanil
Atovaquone
MoA: depolarizes parasitic mitochondria and inhibits their electron transport
Selectivity: plasmodial electron transport
Toxicity: drug interactions
Proguanil (metabolite of atovaquone)
MoA: inhibits DHFR
Selectivity: plasmodial enzyme DHFR; slow onset
Toxicity: GI disturbances
Chloroquine
MoA: Disrupts sequestration of heme as hemozoin; keeps heme in toxic form
Selectivity: parasitized RBC concentrates Chloroquine 25x more than unparasitized RBC and accumulated in the acidic pH of food vacuole
Toxicity: visual accommodation, large doses = blindness
Doxycycline
MoA: Inhibits protein synthesis by binding to the 30S ribosomal subunit
Selectivity:
Toxicity: Photosensitivity Rash
Mefloquine
MoA: unknown; may disrupt sequestration of heme as hemozoin
Selectivity: Unknown
Toxicity: Neuropsychiatric reactions, N/V
Primaquine
MoA: unknown; reactive oxygen species or interfering with electron transport in the parasite
Selectivity: unknown; eradicates hypnozoite forms dormant in liver
Toxicity: N/V, leukopenia, hemolytic anemia w/ G6PD
Quinine
MoA: unknown; may disrupt sequestration of heme as hemozoin
Selectivity: unknown; used in chloroquine resistant P. falciparum
Toxicity: More toxic than chloroquine; tinnitus, blurred vision, headache, nausea, damage to vision, balance and hearing
Quinidine
MoA: unknown; may disrupt sequestration of heme as hemozoin; blocks Na and K currents (a fib treatment)
Selectivity: unknown; used in chloroquine resistant P. falciparum; given IV
Toxicity: Cardiac problems
Artemisinins and combinations (ACT = artemisinin-based combination therapy)
MoA: Heme iron acts on drug to produce free radical to damage parasite proteins; inhibits Ca2+ ATPase in P. falciparum
Don’t use Artemisinins alone to avoid forming resistance.
Artemether/Lumefantrine
MoA: Unknown
Longer half-life and effective against erythrocytic stage